{"id":"https://openalex.org/W2952275751","doi":"https://doi.org/10.1021/jm990557t","title":"New Proline Mimetics: Synthesis of Thrombin Inhibitors Incorporating Cyclopentane- and Cyclopentenedicarboxylic Acid Templates in the P2 Position. Binding Conformation Investigated by X-ray Crystallography","display_name":"New Proline Mimetics: Synthesis of Thrombin Inhibitors Incorporating Cyclopentane- and Cyclopentenedicarboxylic Acid Templates in the P2 Position. Binding Conformation Investigated by X-ray Crystallography","publication_year":2000,"publication_date":"2000-04-14","ids":{"openalex":"https://openalex.org/W2952275751","doi":"https://doi.org/10.1021/jm990557t","mag":"2952275751","pmid":"https://pubmed.ncbi.nlm.nih.gov/10794688"},"language":"en","primary_location":{"id":"doi:10.1021/jm990557t","doi":"https://doi.org/10.1021/jm990557t","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm990557t","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066930684","display_name":"Daniel N\u00f6teberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102134673","display_name":"Link\u00f6ping University","ror":"https://ror.org/05ynxx418","country_code":"SE","type":"education","lineage":["https://openalex.org/I102134673"]},{"id":"https://openalex.org/I161593684","display_name":"Stockholm University","ror":"https://ror.org/05f0yaq80","country_code":"SE","type":"education","lineage":["https://openalex.org/I161593684"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Daniel N\u00f6teberg","raw_affiliation_strings":["Department of Chemistry, Link\u00f6ping University, S-581 83 Link\u00f6ping, Sweden, Department of Medicinal Chemistry, AstraZeneca, S-431 83 M\u00f6lndal, Sweden, and Department of Organic Chemistry, Stockholm University, S-106 91 Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Link\u00f6ping University, S-581 83 Link\u00f6ping, Sweden, Department of Medicinal Chemistry, AstraZeneca, S-431 83 M\u00f6lndal, Sweden, and Department of Organic Chemistry, Stockholm University, S-106 91 Stockholm, Sweden","institution_ids":["https://openalex.org/I102134673","https://openalex.org/I161593684"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002068548","display_name":"Jonas Br\u00e5nalt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102134673","display_name":"Link\u00f6ping University","ror":"https://ror.org/05ynxx418","country_code":"SE","type":"education","lineage":["https://openalex.org/I102134673"]},{"id":"https://openalex.org/I161593684","display_name":"Stockholm University","ror":"https://ror.org/05f0yaq80","country_code":"SE","type":"education","lineage":["https://openalex.org/I161593684"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Jonas Br\u00e5nalt","raw_affiliation_strings":["Department of Chemistry, Link\u00f6ping University, S-581 83 Link\u00f6ping, Sweden, Department of Medicinal Chemistry, AstraZeneca, S-431 83 M\u00f6lndal, Sweden, and Department of Organic Chemistry, Stockholm University, S-106 91 Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Link\u00f6ping University, S-581 83 Link\u00f6ping, Sweden, Department of Medicinal Chemistry, AstraZeneca, S-431 83 M\u00f6lndal, Sweden, and Department of Organic Chemistry, Stockholm University, S-106 91 Stockholm, Sweden","institution_ids":["https://openalex.org/I102134673","https://openalex.org/I161593684"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009335014","display_name":"Ingemar Kvarnstr\u00f6m","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102134673","display_name":"Link\u00f6ping University","ror":"https://ror.org/05ynxx418","country_code":"SE","type":"education","lineage":["https://openalex.org/I102134673"]},{"id":"https://openalex.org/I161593684","display_name":"Stockholm University","ror":"https://ror.org/05f0yaq80","country_code":"SE","type":"education","lineage":["https://openalex.org/I161593684"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Ingemar Kvarnstr\u00f6m","raw_affiliation_strings":["Department of Chemistry, Link\u00f6ping University, S-581 83 Link\u00f6ping, Sweden, Department of Medicinal Chemistry, AstraZeneca, S-431 83 M\u00f6lndal, Sweden, and Department of Organic Chemistry, Stockholm University, S-106 91 Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Link\u00f6ping University, S-581 83 Link\u00f6ping, Sweden, Department of Medicinal Chemistry, AstraZeneca, S-431 83 M\u00f6lndal, Sweden, and Department of Organic Chemistry, Stockholm University, S-106 91 Stockholm, Sweden","institution_ids":["https://openalex.org/I102134673","https://openalex.org/I161593684"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084883305","display_name":"Marcel R. Linschoten","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102134673","display_name":"Link\u00f6ping University","ror":"https://ror.org/05ynxx418","country_code":"SE","type":"education","lineage":["https://openalex.org/I102134673"]},{"id":"https://openalex.org/I161593684","display_name":"Stockholm University","ror":"https://ror.org/05f0yaq80","country_code":"SE","type":"education","lineage":["https://openalex.org/I161593684"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Marcel Linschoten","raw_affiliation_strings":["Department of Chemistry, Link\u00f6ping University, S-581 83 Link\u00f6ping, Sweden, Department of Medicinal Chemistry, AstraZeneca, S-431 83 M\u00f6lndal, Sweden, and Department of Organic Chemistry, Stockholm University, S-106 91 Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Link\u00f6ping University, S-581 83 Link\u00f6ping, Sweden, Department of Medicinal Chemistry, AstraZeneca, S-431 83 M\u00f6lndal, Sweden, and Department of Organic Chemistry, Stockholm University, S-106 91 Stockholm, Sweden","institution_ids":["https://openalex.org/I102134673","https://openalex.org/I161593684"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089491665","display_name":"Djordje M\u00fcsil","orcid":"https://orcid.org/0000-0001-7889-2940","observed_orcids":["https://orcid.org/0000-0001-7889-2940"]},"institutions":[{"id":"https://openalex.org/I102134673","display_name":"Link\u00f6ping University","ror":"https://ror.org/05ynxx418","country_code":"SE","type":"education","lineage":["https://openalex.org/I102134673"]},{"id":"https://openalex.org/I161593684","display_name":"Stockholm University","ror":"https://ror.org/05f0yaq80","country_code":"SE","type":"education","lineage":["https://openalex.org/I161593684"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Djordje Musil","raw_affiliation_strings":["Department of Chemistry, Link\u00f6ping University, S-581 83 Link\u00f6ping, Sweden, Department of Medicinal Chemistry, AstraZeneca, S-431 83 M\u00f6lndal, Sweden, and Department of Organic Chemistry, Stockholm University, S-106 91 Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Link\u00f6ping University, S-581 83 Link\u00f6ping, Sweden, Department of Medicinal Chemistry, AstraZeneca, S-431 83 M\u00f6lndal, Sweden, and Department of Organic Chemistry, Stockholm University, S-106 91 Stockholm, Sweden","institution_ids":["https://openalex.org/I102134673","https://openalex.org/I161593684"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006203194","display_name":"Jan-Erik Nystr\u00f6m","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102134673","display_name":"Link\u00f6ping University","ror":"https://ror.org/05ynxx418","country_code":"SE","type":"education","lineage":["https://openalex.org/I102134673"]},{"id":"https://openalex.org/I161593684","display_name":"Stockholm University","ror":"https://ror.org/05f0yaq80","country_code":"SE","type":"education","lineage":["https://openalex.org/I161593684"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Jan-Erik Nystr\u00f6m","raw_affiliation_strings":["Department of Chemistry, Link\u00f6ping University, S-581 83 Link\u00f6ping, Sweden, Department of Medicinal Chemistry, AstraZeneca, S-431 83 M\u00f6lndal, Sweden, and Department of Organic Chemistry, Stockholm University, S-106 91 Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Link\u00f6ping University, S-581 83 Link\u00f6ping, Sweden, Department of Medicinal Chemistry, AstraZeneca, S-431 83 M\u00f6lndal, Sweden, and Department of Organic Chemistry, Stockholm University, S-106 91 Stockholm, Sweden","institution_ids":["https://openalex.org/I102134673","https://openalex.org/I161593684"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078002439","display_name":"Guido Zuccarello","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102134673","display_name":"Link\u00f6ping University","ror":"https://ror.org/05ynxx418","country_code":"SE","type":"education","lineage":["https://openalex.org/I102134673"]},{"id":"https://openalex.org/I161593684","display_name":"Stockholm University","ror":"https://ror.org/05f0yaq80","country_code":"SE","type":"education","lineage":["https://openalex.org/I161593684"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Guido Zuccarello","raw_affiliation_strings":["Department of Chemistry, Link\u00f6ping University, S-581 83 Link\u00f6ping, Sweden, Department of Medicinal Chemistry, AstraZeneca, S-431 83 M\u00f6lndal, Sweden, and Department of Organic Chemistry, Stockholm University, S-106 91 Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Link\u00f6ping University, S-581 83 Link\u00f6ping, Sweden, Department of Medicinal Chemistry, AstraZeneca, S-431 83 M\u00f6lndal, Sweden, and Department of Organic Chemistry, Stockholm University, S-106 91 Stockholm, Sweden","institution_ids":["https://openalex.org/I102134673","https://openalex.org/I161593684"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112790292","display_name":"Bertil Samuelsson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102134673","display_name":"Link\u00f6ping University","ror":"https://ror.org/05ynxx418","country_code":"SE","type":"education","lineage":["https://openalex.org/I102134673"]},{"id":"https://openalex.org/I161593684","display_name":"Stockholm University","ror":"https://ror.org/05f0yaq80","country_code":"SE","type":"education","lineage":["https://openalex.org/I161593684"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Bertil Samuelsson","raw_affiliation_strings":["Department of Chemistry, Link\u00f6ping University, S-581 83 Link\u00f6ping, Sweden, Department of Medicinal Chemistry, AstraZeneca, S-431 83 M\u00f6lndal, Sweden, and Department of Organic Chemistry, Stockholm University, S-106 91 Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Link\u00f6ping University, S-581 83 Link\u00f6ping, Sweden, Department of Medicinal Chemistry, AstraZeneca, S-431 83 M\u00f6lndal, Sweden, and Department of Organic Chemistry, Stockholm University, S-106 91 Stockholm, Sweden","institution_ids":["https://openalex.org/I102134673","https://openalex.org/I161593684"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5112790292"],"corresponding_institution_ids":["https://openalex.org/I102134673","https://openalex.org/I161593684"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":1.9266,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.84692622,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"43","issue":"9","first_page":"1705","last_page":"1713"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.8090999722480774,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.8090999722480774,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.061400000005960464,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.049800001084804535,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thrombin-inhibitors","display_name":"thrombin inhibitors","score":0.9819999933242798},{"id":"https://openalex.org/keywords/isosteres","display_name":"isosteres","score":0.6069999933242798},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.9070000052452087},{"id":"https://openalex.org/keywords/x-ray-crystal-structure","display_name":"X-ray crystal structure","score":0.7350000143051147}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9363230466842651},{"id":"https://openalex.org/C2778556512","wikidata":"https://www.wikidata.org/wiki/Q80260","display_name":"Cyclopentane","level":2,"score":0.714806318283081},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.6074146032333374},{"id":"https://openalex.org/C2779815552","wikidata":"https://www.wikidata.org/wiki/Q484583","display_name":"Proline","level":3,"score":0.4896255135536194},{"id":"https://openalex.org/C82714645","wikidata":"https://www.wikidata.org/wiki/Q438331","display_name":"Template","level":2,"score":0.4679253101348877},{"id":"https://openalex.org/C2777292125","wikidata":"https://www.wikidata.org/wiki/Q409166","display_name":"Thrombin","level":3,"score":0.4324289560317993},{"id":"https://openalex.org/C2779328170","wikidata":"https://www.wikidata.org/wiki/Q34777","display_name":"X-ray","level":2,"score":0.4212000370025635},{"id":"https://openalex.org/C8010536","wikidata":"https://www.wikidata.org/wiki/Q160398","display_name":"Crystallography","level":1,"score":0.4196305274963379},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.3057931065559387},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23507460951805115},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.09985965490341187},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.0},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001777","descriptor_name":"Blood Coagulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003517","descriptor_name":"Cyclopentanes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003517","descriptor_name":"Cyclopentanes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007202","descriptor_name":"Indicators and Reagents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009682","descriptor_name":"Magnetic Resonance Spectroscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011392","descriptor_name":"Proline","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011487","descriptor_name":"Protein Conformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013698","descriptor_name":"Templates, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013917","descriptor_name":"Thrombin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D013917","descriptor_name":"Thrombin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D018360","descriptor_name":"Crystallography, X-Ray","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm990557t","doi":"https://doi.org/10.1021/jm990557t","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm990557t","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:10794688","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10794688","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.428600013256073,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1539796472","https://openalex.org/W1624840895","https://openalex.org/W1775065314","https://openalex.org/W1964550833","https://openalex.org/W1965135729","https://openalex.org/W1982262848","https://openalex.org/W1985407614","https://openalex.org/W1986358267","https://openalex.org/W1986758094","https://openalex.org/W2001203438","https://openalex.org/W2003978987","https://openalex.org/W2005593114","https://openalex.org/W2013032882","https://openalex.org/W2024355856","https://openalex.org/W2028015715","https://openalex.org/W2043305221","https://openalex.org/W2062603699","https://openalex.org/W2062801508","https://openalex.org/W2070990237","https://openalex.org/W2079280373","https://openalex.org/W2083828059","https://openalex.org/W2087712132","https://openalex.org/W2155717144","https://openalex.org/W2324431138","https://openalex.org/W2347155918","https://openalex.org/W2419277395","https://openalex.org/W2949362981","https://openalex.org/W2949602771","https://openalex.org/W2951849446","https://openalex.org/W2952163460","https://openalex.org/W4213438061","https://openalex.org/W4248350760"],"related_works":["https://openalex.org/W2020711353","https://openalex.org/W2033496659","https://openalex.org/W1971781273","https://openalex.org/W1982799228","https://openalex.org/W2016358692","https://openalex.org/W2058319103","https://openalex.org/W2055758302","https://openalex.org/W2158814095","https://openalex.org/W2174441395","https://openalex.org/W2095168548"],"abstract_inverted_index":{"With":[0],"the":[1,8,12,25,53,69,76],"aim":[2],"to":[3,75],"prepare":[4],"nonpeptidic":[5],"thrombin":[6,67],"inhibitors,":[7],"amino":[9],"acids":[10],"of":[11,46,52],"thrombin-inhibiting":[13],"tripeptide":[14],"chain":[15],"D-Phe-Pro-Arg":[16],"were":[17],"replaced":[18,23],"with":[19,24,33,43,66],"isosteres.":[20],"Arg":[21],"was":[22,64],"more":[26],"rigid":[27],"P1":[28],"truncated":[29],"p-amidinobenzylamine":[30],"(Pab),":[31],"Pro":[32],"either":[34],"cyclopentane-1,":[35],"2-dicarboxylic":[36],"acid":[37],"or":[38],"cyclopentene-1,5-dicarboxylic":[39],"acid,":[40],"and":[41],"D-Phe":[42],"a":[44],"series":[45,63],"readily":[47],"available":[48],"lipophilic":[49],"amines.":[50],"One":[51],"most":[54],"potent":[55],"compounds":[56],"(25,":[57],"pIC(50)":[58],"=":[59],"6.01)":[60],"in":[61],"these":[62],"cocrystallized":[65],"where":[68],"X-ray":[70],"crystal":[71],"structure":[72],"provide":[73],"insight":[74],"structure-activity":[77],"relationship":[78],"(SAR).":[79]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-06-27T00:00:00"}